ICD-10-CM Billable Code

N80.B6

Endometriosis of cardiothoracic space

Clinical Classification Guidelines

Medical Intelligence & Overview

Endometriosis of the cardiothoracic space is a rare condition where tissue similar to the lining inside the uterus (endometrial tissue) grows in the area around the heart and lungs within the chest cavity. This abnormal tissue growth can cause pain and other health issues, although it is an uncommon form of endometriosis. This article explains what this condition is, its causes, symptoms, ways it is diagnosed, and potential treatment options to provide clarity for patients and caregivers.

Causes & Symptoms

Clinical Causes: Retrograde menstruation, where menstrual blood flows backward through the fallopian tubes into the pelvic cavity, might, in rare cases, extend to higher areas such as the chest. Coelomic metaplasia, a process where cells lining the chest cavity transform into endometrial-like tissue. Lymphatic or hematogenous spread, where endometrial cells travel through the lymphatic system or blood vessels to reach the chest area. Genetic predisposition, making some individuals more susceptible to ectopic tissue growth. Previous chest surgeries or trauma, which might facilitate the implantation of endometrial tissue in the thoracic area. Hormonal influences, particularly estrogen, which can stimulate growth of endometrial tissue regardless of its location.

Key Symptoms: Chest pain that may worsen during menstruation or with physical activity. Shortness of breath or difficulty breathing. Cough, which may be dry or productive. Pain or discomfort in the shoulder, back, or chest area. Swelling or lumps in the chest or neck area. Unusual bleeding or spotting around the chest or involving the respiratory or cardiac regions. Palpitations or irregular heartbeats if the tissue affects the heart structures. Pain that correlates with the menstrual cycle, indicating hormonal influence.

Diagnostic & Treatment

Diagnosis Path: Imaging studies, including chest X-rays, ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI), to visualize abnormal tissue growth. Laboratory tests, such as blood work, to rule out infections or other causes of chest symptoms. Video-assisted thoracoscopic surgery (VATS), a minimally invasive procedure, allowing direct visualization and biopsy of the abnormal tissue for confirmation. Histopathological examination of tissue samples to identify endometrial tissue by detecting characteristic glandular and stromal cells.

Treatment Protocols: Hormonal therapy, such as gonadotropin-releasing hormone (GnRH) agonists or antagonists, to suppress estrogen production and reduce the growth of endometrial tissue. Pain management with medications like NSAIDs (nonsteroidal anti-inflammatory drugs), to reduce discomfort. Surgical intervention to remove ectopic tissue, especially if it causes significant symptoms or complications like compression of vital structures. In some cases, combining medical therapy with surgery offers the best outcomes. Regular follow-up and monitoring to detect any recurrence or progression of the condition.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N80.B6 a billable ICD-10 code?
Yes, N80.B6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N80.B6?
Clinical documentation must specify the nature of Endometriosis of cardiothoracic space and any associated comorbidities for accurate reporting.

Cite this Clinical Reference